Zobrazeno 1 - 2
of 2
pro vyhledávání: '"And on behalf of the PLCRC-MEDOCC group"'
Autor:
S. J. Schraa, K. L. van Rooijen, D. E. W. van der Kruijssen, C. Rubio Alarcón, J. Phallen, M. Sausen, J. Simmons, V. M. H. Coupé, W. M. U. van Grevenstein, S. Elias, H. M. Verkooijen, M. M. Laclé, L. J. W. Bosch, D. van den Broek, G. A. Meijer, V. E. Velculescu, R. J. A. Fijneman, G. R. Vink, M. Koopman, And on behalf of the PLCRC-MEDOCC group
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Accurate detection of patients with minimal residual disease (MRD) after surgery for stage II colon cancer (CC) remains an urgent unmet clinical need to improve selection of patients who might benefit form adjuvant chemotherapy (A
Externí odkaz:
https://doaj.org/article/40d7bd3d88bd47d7995d5947b7f7549b
Autor:
Schraa, S. J., van Rooijen, K. L., van der Kruijssen, D. E. W., Rubio Alarcón, C., Phallen, J., Sausen, M., Simmons, J., Coupé, V. M. H., van Grevenstein, W. M. U., Elias, S., Verkooijen, H. M., Laclé, M. M., Bosch, L. J. W., van den Broek, D., Meijer, G. A., Velculescu, V. E., Fijneman, R. J. A., Vink, G. R., Koopman, M., And on behalf of the PLCRC-MEDOCC group
Publikováno v:
BMC Cancer; 8/20/2020, Vol. 20 Issue 1, pN.PAG-N.PAG, 1p, 1 Diagram, 1 Chart